Prevalence of anelloviruses (TTV, TTMDV, and TTMV) in healthy blood donors and in patients infected with HBV or HCV in Qatar
© The Author(s). 2016
Received: 17 June 2016
Accepted: 2 December 2016
Published: 28 December 2016
The Erratum to this article has been published in Virology Journal 2017 14:143
Anelloviruses (TTV, TTMV, and TTMDV) have been associated with non A-G hepatitis. The goal of the current study was to estimate the prevalence of these anelloviruses in Qatar.
A total of 607 blood samples (500 healthy donors, and 53 HBV-and 54 HCV-positive patients) representing different nationalities were tested for the presence of TTV, TTMV, and TTMDV DNA by nested PCR.
Prevalence rates for the three viruses were high in all studied groups, and exceeding 95% in the HBV group (for TTV and TTMDV). Infection with more than one type of viruses was common and significant in most of the positive patients (p < 0.05) and ranging from 55.4% for TTV/TTMV and TTMV/TTMDV co-infections in the healthy group, to 96.3% for TTV/TTMV co-infections in the HBV group. Further, and as with most previous studies, no significant association was found between anelloviruses infections and age, nationality, or gender (p > 0.05) albeit the detection of higher infection rates among females and Qatari subjects.
This was the first published study to look at prevalence of Anellowviruses in the Middle East. High prevalence rates of the three viruses in all studied groups was noted. Further studies are needed to explore and compare the different genotypes of these viruses in the region.
Human infections with anelloviruses (small ssDNA viruses) are widely spread [1, 2]. A prominent member of the Anelloviridae family is the Torque teno virus (TTV), reported for the first time in 1997 in a Japanese patient with post-transfusion hepatitis of unknown etiology . Subsequently (in 2000), another small DNA virus, designated Torque teno mini virus (TTMV), remotely similar to TTV was discovered . In 2007 a third addition to the anellovirus genus was reported; the new virus had a genome of 3.2 kb (TTV and TTMV were around 3.8 and 2.8 kb, respectively), hence the designation Torque teno midi virus (TTMDV) . The Anelloviridae family contains 12 genera; TTV, TTMV, and TTMDV belong to Alphatorquevirus, Betatorquevirus, and Gammatorquevirus, genera respectively .
The Alphatorquevirus genera (TTV) alone has 29 species. Much less is known about phylogenetic groups for TTMV and TTMDV ; TTMV ORF1 sequence comparison showed significant divergence, and complete genome analysis of TTMDV also shows sequences clustering .
The three viruses share a similar genome organization (UTR region, open reading frame region followed by short G/C rich region). Further, the three viruses are extremely divergent in the ORF regions both at the nucleotide and amino acid levels .
Furthermore, infection with anelloviruses can be highly common reaching a 90% prevalence rate . Reports on the prevalence of TTMV in humans indicated high rates of infection in French , Brazilian [10, 11] and in Norwegian  blood donors and also in French hemodialysis patients (95%) . Further, TTMV DNA has been detected in amniotic fluid, cord blood and breast milk [10, 14]. TTMV DNA has also been detected in cervical swabs of healthy women , women diagnosed with cervical cancers, peripheral blood mononuclear cells, feces and saliva .
TTMDV DNA was detected in plasma and saliva samples of French blood donors , in healthy and hepatitis C Italian serum samples , in healthy blood donors, hepatitis C patients and HIV patients in Iran , and in Korean chronic hepatitis patients and blood products . TTMDV was also reported in Hungarian children with acute respiratory disease .
Since TTV was first detected in blood samples it was referred to as transfusion-transmitted (TT) virus . Subsequent studies suggested the existence of other ways of TTV transmission including parenteral, sexual, vertical and others .
TTV has been detected in almost every human tissue type or body fluid, the newly discovered TTMV can be transmitted from mother to baby; similar virus sequences in mother and baby were detected in umbilical cord blood, breast milk, amniotic fluid, and sera of newborns .
The aim of the current study was to investigate the rates of infection of TTV, TTMV, and TTMDV in Qatar, and to examine the association of these virus infections, if any, with HBV or HCV.
Prior to samples collection from patients and blood donors, Institutional Review Board of Hamad Medical Corporation (HMC) (Protocol No.13422/13) and Qatar University (IRB No. QU-IRB289-A/14) approvals were obtained. Furthermore, because this research involves no risk to the participants, a waiver of all the consent requirements was obtained. The participants’ rights and welfare were not harmfully affected, because personal information related to participants was not claimed. Blood samples obtained from the blood bank and the hospital were anonymous. The only information collected related to the participants were nationality, sex, and age. Information concerning collected data was kept confidential.
Blood samples collection
The samples that were used in this project to detect TTMDV and TTMV DNA were exactly the same ones we used in our previous TTV published project , and the data from it were used again in this study for comparison purposes between the three anelloviruses.
A total of 500 samples from healthy blood donors were used in the present study. These samples were collected from the blood donation unit during the period from June to August 2013. In addition, blood samples from 54 infected HBV to 53 HCV patients were also obtained from the diagnostic virology laboratory at the HMC.
Plasma DNA extraction
DNA was extracted from 200 μl aliquots of plasma using a standard commercial kit for viral DNA extraction from body fluids (PureLink® Viral RNA/DNA Kits - Life Technologies; Grand Island, New York, USA).
Whole genome amplification of DNA
Due to small sample volume, extracted DNA was amplified using REPLI-g Mini Kit (Catalog # 150025, Qiagen, USA) following manufacturer’s protocol. Amplified DNA was stored at −20 °C until use.
Detection of TTMDV and TTMV
Both viruses were detected using nested PCR. For the first round PCR setup, the following components were used: one μl of whole genome amplified DNA, 10 pmol each of forward and reverse primers (universal primers) as described previously  and GoTaq Green Master Mix (Promega, Madison, WI, USA) in a reaction volume of 50 μl (μl). The mixture was preheated at 95°C for 5 min followed by 35 cycles with parameters as follows: 95°C for 30 s, 55°C for 30 s, 72°C for 30 s, and a final extension of 72 °C for 5 min. For the second round, two PCR reactions to detect TTMDV and TTMV were separately prepared. For the detection of TTMDV, the reaction mixture consisted of 5 μl of the amplification product of the first round, 15 pmol of NG795/NG796 primers  and GoTaq Green Master Mix with a total volume of 40 μl. The mixture was preheated at 95°C for 5 min followed by 30 cycles of 95°C for 20 s, 62°C for 20 s, 72°C for 20 s, and a final extension of 72°C for 5 min. The same conditions were used to detect TTMV except that the primers NG792/NG793/NG794 as sense primers and NG791 as antisense primer were used . Fifteen μl of the amplified products were electrophoresed in 2.5% agarose gel, stained with GreenView Plus (GeneCopoeia, USA), and photographed under UV light.
Data were analyzed using SPSS software. The chi-square test was used to compare proportions between the groups. Differences were considered to be statistically significant at was p < 0.05.
Study population analysis
Characteristics of the subjects (n = 607)
Healthy (n = 500) n (%)
HBV (n = 54) n (%)
HCV (n = 53) n (%)
Age range (Average ± SD)
13 − 80 (36 ± 10.6)
19 − 74 (36 ± 9.3)
13 − 74 (34.9 ± 12.0)
15 − 80 (45 ± 14.9)
Anelloviruses infection rates in the different populations
TTV, TTMV, and TTMDV distribution in study groups
Healthy (n = 500) n (%)
HBV (n = 54) n (%)
HCV (n = 53) n (%)
We also noticed that patients co-infected with HBV or HCV showed significantly (p <0.05) higher infection rates with anelloviruses than the healthy blood donors. The only exception was in the insignificant association between TTV and HCV infection. A closer look at Table 2 revealed that the highest prevalence of the three viruses was among the HBV followed by the HCV- infected patients.
Analysis of mixed infections
Association between TTV, TTMV, and TTMDV in different study populations
TTMDV n (%)
TTMV n (%)
Healthy (n = 500)
HBV (n = 54)
HCV (n = 53)
TTV, TTMV, and TTMDV distribution in study groups (n = 607)
TTV n (%)
TTMDV n (%)
TTMV n (%)
TTV, TTMV, and TTMDV distribution in different nationalities (n = 607)
Qatar (=81) n (%)
Asia (n = 345) n (%)
Africa (n = 156) n (%)
Others (n = 25) n (%)
Further, as shown in Table 5, there was no significant differences in the prevalence of TTV, TTMDV, and TTMV among the different ethnic or nationality groups residing in Qatar, which further suggests that nationalities or population origin has no effect on the prevalence of these viruses in Qatar.
Since their discovery, the three anelloviruses TTV, TTMV, and TTMDV shared some common features such as their detection in the blood of healthy donors and in HBV/HCV pationts. The presence of the viruses in non- A to G hepatitis patients, linked them to hepatitis. This probably justifies the number of studies, specially on TTV, that evaluated the prevalence of the virus in HBV and HCV blood samples compared to the limited number of studies in healthy individuals especially in the Middle East region. In a previous study  we reported our finding concerning the prevalence of TTV in healthy blood donors and HBV/HBC patients in Qatar. Therefore, the objective of this study was to evaluate the TTMV and TTMDV prevalence rates in healthy, as well as, HBV and HCV subjects in Qatar and compare the findings to those in the previous TTV study.
The current study was conducted on a total of 607 blood samples from healthy blood donors (n = 500), subjects with HBV (n = 54) or HBC (n = 53). Findings of the present study showed an overall high prevalence rates of the three viruses (Fig. 1); TTV prevalence rates (85.2%t) were significantly higher (p < 0.05) than the other two viruses (76.3 and 66.6% for TTMDV, and TTMV, respectively). A closer comparative look at the ditribution of the three viruses in the different study groups (healthy, HBV, and HCV) revealed interesting findings. Firstly, the incidences of the three viruses were significantly high in the HBV and HCV groups as compared to the healthy group (p < 0.05) (Table 2); prevalence rates were even highre in the HBV group (reaching 98% in the HBV group for TTMDV). Secondly, the prevalence rates of the three viruses were significantly different in the healthy (p < 0.001) and HBV (p < 0.04) groups but not in the HCV group (Table 2).
Further, most of the tested samples, regarless of the study group, yielded mixed infections; the highest association was seen in the HBV group between TTV and TTMV (96.3% of the samples); most of the associations were significant (p < 0.05) except for the mixed TTV/TTMDV infecitons in the HBV group and TTMDV/TTMV mixed infections in the HCV group (Table 3).
Prevalence rates for the three viruses were not significantly different in relation to gender, nationality or age (Table 4) (p > 0.05), albeit the slightly higher infection rates in females and Qatari nationals. A closer look at the overall distribution of the viruses in different ethnic backgrounds as compared to Qatari nationals revealed higher rates in Qataris and “others” compared to Asians and Africans (p > 0.05) (Table 5).
There is great prevalence variation of anelloviruses in different regions of the world. This variability can be explained in different ways; it is probably a true representation of the ubiquity of the viruses; it can be also attributed to the choice of DNA target region amplified and PCR primers used.
The high prevalence rates of anelloviruses viremias in this study, and other studies for that matter, can be also explained in part, by the ease of transmission of the virus.
Compared to TTV, much less is known about the prevalence rates of the TTMV and TTMDV in healthy individuals, as well as HBV and HBC patients. Earlier reports on the prevalence of TTMV in other regions indicated comperable infection rates in blood donors from France (76–77%) , Brazil (72–77%) [10, 11] and Norway (48%) . Furthermore, lower prevalence rates were previously reported in healthy blood donors in Korea (41.3%)  and Iran (17%) .
With regards to TTMDV, the viremia frequency of the virus in healthy individuals was 14.5% in Iran , 34.5% in Korea , 20% in France , and 8.6% in Italian blood donors . Those findings are much lower than the 74.6% reported in the current study in Qatar.
Due to the scarcity of data regarding the incidence of TTMV and TTMDV in HBV- or HCV-positive subjects, it became more difficult to make any comparative analysis. An earlier study in Iran reported incidence rate of 20% (5/25) and 48% (12/25) of TTMV in HBV and HCV subjects . Further, Garcia-Alvarez et al. reported a very high incidence rate of TTV and TTMV in HIV/HCV-coinfected patients, which is higher than the 83% infection rate in HCV patients in the current study . Also, in another study in Iran, researchers reported a TTMDV incidence rate of 80.5% (29/36) and 75% (3/4) in HIV/HCV and HIV/HCV/HBV coinfected patients, respectively , which was lower than the 88.7 and 98.1% TTMDV infection rates obtained in HCV and HBV infected patients in the current study (Table 2).
High frequencies of TTMV and TTMDV among HBV and HBC patients in comparison to low frequencies in healthy blood donors suggest common infection routes, highly compatible with these viruses, such as blood and sex.
Moreover, coinfection with multiple TT viruses seems to be a common event [28–30]. One explanation for the mixed infections with different anelloviruses seen in the current study and other studies would be that the viruses may have similar and probably synergystic infection cycles that help viruses from the same family better adapt to the environment. Another explanation would be that these viruses probably infect the same cell types permitting the viruses to favorably replicate in the same cells.
In conclusion, this study showed a high prevalence (>75%) of the three anelloviruses (TTV, TTMDV, and TTMV) in the Middle East. Further studies are needed to explore and compare the different genotypes of these viruses in the region.
We are grateful to: Mr. Tameem Hadwan, Mr. Abdullfattah Nasrallah, and Mrs. Mooza A. Al-Kinji and the students Aisha Khan, Nadima Ali, and Maria Khalid Samati for their technical support. We also would like to thank Ms. Sana M. Abohasera and Mrs. Faten H. Sawali from the Blood Donor Center at HMC for their help in blood sample and donor demographic data collection. This report (publication) was made possible by UREP grant # (UREP 15-015-3-006) from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the author(s). This study was approved by the Hamad Medical Center Research Committee (Protocol #13422/13).
This work was made possible by UREP grant # (UREP 15-015-3-006) from the Qatar National Research Fund (a member of Qatar Foundation).
GNK and ESA collected samples, extracted DNA and prepared figures and tables. RA did the write up and revisions. LT performed the statistical analyses and data interpretation, MEZ helped in data entry, draw figure 1, and in table's constructions, and AAA conducted all PCR experiments of all samples. Further, GKN and RA supervised the entire work. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Ethics approval and consent to participate
Prior to samples collection from patients and blood donors, Institutional Review Board of Hamad Medical Corporation (HMC) (Protocol No.13422/13) and Qatar University (IRB No. QU-IRB289-A/14) approvals were obtained. The participants’ rights and welfare were not harmfully affected, because personal information related to participants was not claimed. Blood samples obtained from the blood bank and the hospital were anonymous. The only information collected related to the participants were nationality, sex, and age. Information concerning collected data was kept confidential.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Hino S, Miyata H. Torque teno virus (TTV): current status. Rev Med Virol. 2007;17:45–57.View ArticlePubMedGoogle Scholar
- Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM, Ellender J, Yap PL, Ludlam CA, Haydon GH, Gillon J, Jarvis LM. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet. 1998;352:191–5.View ArticlePubMedGoogle Scholar
- Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun. 1997;241:92–7.View ArticlePubMedGoogle Scholar
- Takahashi K, Iwasa Y, Hijikata M, Mishiro S. Identification of a new human DNA virus (TTV-like mini virus, TLMV) intermediately related to TT virus and chicken anemia virus. Arch Virol. 2000;145:979–93.View ArticlePubMedGoogle Scholar
- Ninomiya M, Nishizawa T, Takahashi M, Lorenzo FR, Shimosegawa T, Okamoto H. Identification and genomic characterization of a novel human torque teno virus of 3.2 kb. J Gen Virol. 2007;88:1939–44.View ArticlePubMedGoogle Scholar
- Biagini P. Classification of TTV and related viruses (anelloviruses). Curr Top Microbiol Immunol. 2009;331:21–33.PubMedGoogle Scholar
- Spandole S, Cimponeriu D, Berca LM, Mihaescu G. Human anelloviruses: an update of molecular, epidemiological and clinical aspects. Arch Virol. 2015;160:893–908.View ArticlePubMedGoogle Scholar
- AbuOdeh R, Al-Mawlawi N, Al-Qahtani AA, Bohol MF, Al-Ahdal MN, Hasan HA, AbuOdeh L, Nasrallah GK. Detection and genotyping of torque teno virus (TTV) in healthy blood donors and patients infected with HBV or HCV in Qatar. J Med Virol. 2015;87:1184–91.View ArticlePubMedGoogle Scholar
- Biagini P, Gallian P, de Micco P, de Lamballerie X. TT virus and TT virus-like mini-virus infection in french blood donors. Transfusion. 2000;40:1542.View ArticlePubMedGoogle Scholar
- Vasconcelos HC, Cataldo M, Niel C. Mixed infections of adults and children with multiple TTV-like mini virus isolates. J Med Virol. 2002;68:291–8.View ArticlePubMedGoogle Scholar
- Niel C, Lampe E. High detection rates of TTV-like mini virus sequences in sera from Brazilian blood donors. J Med Virol. 2001;65:199–205.View ArticlePubMedGoogle Scholar
- Moen EM, Huang L, Grinde B. Molecular epidemiology of TTV-like mini virus in Norway. Arch Virol. 2002;147:181–5.View ArticlePubMedGoogle Scholar
- Gallian P, Biagini P, Attoui H, Cantaloube JF, Dussol B, Berland Y, de Micco P, de Lamballerie X. High genetic diversity revealed by the study of TLMV infection in French hemodialysis patients. J Med Virol. 2002;67:630–5.View ArticlePubMedGoogle Scholar
- Matsubara H, Michitaka K, Horiike N, Kihana T, Yano M, Mori T, Onji M. Existence of TT virus DNA and TTV-like mini virus DNA in infant cord blood: mother-to-neonatal transmission. Hepatol Res. 2001;21:280–7.View ArticlePubMedGoogle Scholar
- Fornai C, Maggi F, Vatteroni ML, Pistello M, Bendinelli M. High prevalence of TT virus (TTV) and TTV-like minivirus in cervical swabs. J Clin Microbiol. 2001;39:2022–4.View ArticlePubMedPubMed CentralGoogle Scholar
- Changani L, Bouzari M, Talebi A. Torque teno mini virus infection in chronic cervicitis and cervical tumors in Isfahan, Iran. Intervirology. 2013;56:265–70.View ArticlePubMedGoogle Scholar
- Biagini P, de Micco P, de Lamballerie X. Identification of a third member of the Anellovirus genus (“small anellovirus”) in French blood donors. Arch Virol. 2006;151:405–8.View ArticlePubMedGoogle Scholar
- Andreoli E, Maggi F, Pistello M, Meschi S, Vatteroni M, Nelli LC, Bendinelli M. Small Anellovirus in hepatitis C patients and healthy controls. Emerg Infect Dis. 2006;12:1175–6.View ArticlePubMedPubMed CentralGoogle Scholar
- Fatholahi M, Bouzari M. Torque Teno Midi Virus/Small Anellovirus in Sera of healthy, HIV/HCV and HIV infected individuals in Lorestan Province, Iran. Jundishapur J Microbiol. 2015;8:e25368.View ArticlePubMedPubMed CentralGoogle Scholar
- Han Th CJY. Detection of small anellovirus DNA from blood products. Kore J Blood Transfus. 2006;17:126–34.Google Scholar
- Burian Z, Szabo H, Szekely G, Gyurkovits K, Pankovics P, Farkas T, Reuter G. Detection and follow-up of torque teno midi virus (“small anelloviruses”) in nasopharyngeal aspirates and three other human body fluids in children. Arch Virol. 2011;156:1537–41.View ArticlePubMedGoogle Scholar
- Vasilyev EV, Trofimov DY, Tonevitsky AG, Ilinsky VV, Korostin DO, Rebrikov DV. Torque Teno Virus (TTV) distribution in healthy Russian population. Virol J. 2009;6:134.View ArticlePubMedPubMed CentralGoogle Scholar
- Ninomiya M, Takahashi M, Nishizawa T, Shimosegawa T, Okamoto H. Development of PCR assays with nested primers specific for differential detection of three human anelloviruses and early acquisition of dual or triple infection during infancy. J Clin Microbiol. 2008;46:507–14.View ArticlePubMedGoogle Scholar
- Ninomiya M, Takahashi M, Shimosegawa T, Okamoto H. Analysis of the entire genomes of fifteen torque teno midi virus variants classifiable into a third group of genus Anellovirus. Arch Virol. 2007;152:1961–75.View ArticlePubMedGoogle Scholar
- Chung JY, Han TH, Seong K, Paik IK, Kim MJ. Transfusion-transmitted virus and TTV-like mini virus infection in blood donors. Korean J Lab Med. 2004;28:250–54.Google Scholar
- Ghazimorad A, Bouzari M, Kardi MT. Frequency of Torque Teno Mini Virus in Hepatitis B and C Patients and Healthy Blood Donors in Isfahan, Iran. Iranian Journal of Blood and Cancer. 2014;6:119–26.Google Scholar
- Chung JY, Han TH, Koo JW, Kim SW, Seo JK, Hwang ES. Small anellovirus infections in Korean children. Emerg Infect Dis. 2007;13:791–3.View ArticlePubMedPubMed CentralGoogle Scholar
- Garcia-Alvarez M, Berenguer J, Alvarez E, Guzman-Fulgencio M, Cosin J, Miralles P, Catalan P, Lopez JC, Rodriguez JM, Micheloud D, et al. Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus. Eur J Clin Microbiol Infect Dis. 2013;32:289–97.View ArticlePubMedGoogle Scholar
- Niel C, de Oliveira JM, Ross RS, Gomes SA, Roggendorf M, Viazov S. High prevalence of TT virus infection in Brazilian blood donors. J Med Virol. 1999;57:259–63.View ArticlePubMedGoogle Scholar
- Luo K, He H, Liu Z, Liu D, Xiao H, Jiang X, Liang W, Zhang L. Novel variants related to TT virus distributed widely in China. J Med Virol. 2002;67:118–26.View ArticlePubMedGoogle Scholar